-
Development of Machine Learning Classifiers for Blood-based Diagnosis and Prognosis of Suspected Acute Infections and Sepsis
Authors:
Ljubomir Buturovic,
Michael Mayhew,
Roland Luethy,
Kirindi Choi,
Uros Midic,
Nandita Damaraju,
Yehudit Hasin-Brumshtein,
Amitesh Pratap,
Rhys M. Adams,
Joao Fonseca,
Ambika Srinath,
Paul Fleming,
Claudia Pereira,
Oliver Liesenfeld,
Purvesh Khatri,
Timothy Sweeney
Abstract:
We applied machine learning to the unmet medical need of rapid and accurate diagnosis and prognosis of acute infections and sepsis in emergency departments. Our solution consists of a Myrna (TM) Instrument and embedded TriVerity (TM) classifiers. The instrument measures abundances of 29 messenger RNAs in patient's blood, subsequently used as features for machine learning. The classifiers convert t…
▽ More
We applied machine learning to the unmet medical need of rapid and accurate diagnosis and prognosis of acute infections and sepsis in emergency departments. Our solution consists of a Myrna (TM) Instrument and embedded TriVerity (TM) classifiers. The instrument measures abundances of 29 messenger RNAs in patient's blood, subsequently used as features for machine learning. The classifiers convert the input features to an intuitive test report comprising the separate likelihoods of (1) a bacterial infection (2) a viral infection, and (3) severity (need for Intensive Care Unit-level care). In internal validation, the system achieved AUROC = 0.83 on the three-class disease diagnosis (bacterial, viral, or non-infected) and AUROC = 0.77 on binary prognosis of disease severity. The Myrna, TriVerity system was granted breakthrough device designation by the United States Food and Drug Administration (FDA). This engineering manuscript teaches the standard and novel machine learning methods used to translate an academic research concept to a clinical product aimed at improving patient care, and discusses lessons learned.
△ Less
Submitted 2 July, 2024;
originally announced July 2024.
-
Physical epistatic landscape of antibody binding affinity
Authors:
Rhys M. Adams,
Justin B. Kinney,
Aleksandra M. Walczak,
Thierry Mora
Abstract:
Affinity maturation produces antibodies that bind antigens with high specificity by accumulating mutations in the antibody sequence. Map** out the antibody-antigen affinity landscape can give us insight into the accessible paths during this rapid evolutionary process. By develo** a carefully controlled null model for noninteracting mutations, we characterized epistasis in affinity measurements…
▽ More
Affinity maturation produces antibodies that bind antigens with high specificity by accumulating mutations in the antibody sequence. Map** out the antibody-antigen affinity landscape can give us insight into the accessible paths during this rapid evolutionary process. By develo** a carefully controlled null model for noninteracting mutations, we characterized epistasis in affinity measurements of a large library of antibody variants obtained by Tite-Seq, a recently introduced Deep Mutational Scan method yielding physical values of the binding constant. We show that representing affinity as the binding free energy minimizes epistasis. Yet, we find that epistatically interacting sites contribute substantially to binding. In addition to negative epistasis, we report a large amount of beneficial epistasis, enlarging the space of high-affinity antibodies as well as their mutational accessibility. These properties suggest that the degeneracy of antibody sequences that can bind a given antigen is enhanced by epistasis - an important property for vaccine design.
△ Less
Submitted 11 December, 2017;
originally announced December 2017.
-
Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves
Authors:
Rhys M. Adams,
Thierry Mora,
Aleksandra M. Walczak,
Justin B. Kinney
Abstract:
Despite the central role that antibodies play in the adaptive immune system and in biotechnology, much remains unknown about the quantitative relationship between an antibody's amino acid sequence and its antigen binding affinity. Here we describe a new experimental approach, called Tite-Seq, that is capable of measuring binding titration curves and corresponding affinities for thousands of varian…
▽ More
Despite the central role that antibodies play in the adaptive immune system and in biotechnology, much remains unknown about the quantitative relationship between an antibody's amino acid sequence and its antigen binding affinity. Here we describe a new experimental approach, called Tite-Seq, that is capable of measuring binding titration curves and corresponding affinities for thousands of variant antibodies in parallel. The measurement of titration curves eliminates the confounding effects of antibody expression and stability that arise in standard deep mutational scanning assays. We demonstrate Tite-Seq on the CDR1H and CDR3H regions of a well-studied scFv antibody. Our data shed light on the structural basis for antigen binding affinity and suggests a role for secondary CDR loops in establishing antibody stability. Tite-Seq fills a large gap in the ability to measure critical aspects of the adaptive immune system, and can be readily used for studying sequence-affinity landscapes in other protein systems.
△ Less
Submitted 15 November, 2016; v1 submitted 9 January, 2016;
originally announced January 2016.
